Spatial control of gene expression within a scaffold by localized inducer release

Biomaterials

Volumn 32, Issue 11, 2011, Pages 3062-3071

  Baraniak, Priya R ^a,b,d   Nelson, Devin M ^a,b   Leeson, Cory E ^a   Katakam, Anand K ^c   Friz, Jennifer L ^c   Cress, Dean E ^c   Hong, Yi ^b   Guan, Jianjun ^b,e   Wagner, William R ^a,b  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c INTREXON CORPORATION   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Controlled release; Elastomer; Gene expression; Spatial control; Tissue engineering

Indexed keywords

BIOACTIVE MOLECULES; BIOMATERIAL SURFACES; CELL EXPRESSION; CONTROLLED RELEASE; EXPRESSION SYSTEM; EXTENDED RELEASE; GENE PRODUCTS; GENETICALLY MODIFIED; GREEN FLUORESCENT PROTEIN; IN-VITRO; IN-VIVO; LOADING DENSITY; MATERIAL SURFACE; MATRIX; POLY(ESTER URETHANE)UREA; POROUS SCAFFOLD; PROGENITOR CELL; SALT LEACHING; SCAFFOLD SYSTEM; SOFT TISSUE; SPATIAL CONTROL;

ELASTOMERS; ESTERS; LEACHING; LIGANDS; SCAFFOLDS; TISSUE; TISSUE ENGINEERING; UREA;

GENE EXPRESSION;

ECDYSONE; ELASTOMER; GREEN FLUORESCENT PROTEIN; POLY(ESTER URETHANE); POLYURETHAN; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ARTICLE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION SYSTEM; LEACHING; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE; STEM CELL; TISSUE REPAIR;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; GENE EXPRESSION; MICE; TISSUE ENGINEERING;

MURINAE;

EID: 79951579163     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.037     Document Type: Article

References (59)

1. Fischbach C., Mooney D.J. Polymers for pro- and anti-angiogenic therapy. Biomaterials 2007, 12:2069-2076.
2. Baker R.E., Maini P.K. Travelling gradients in interacting morphogen systems. Math Biosci 2007, 209(1):30-50.
3. Kennedy T.E., Wang H., Marshall W., Tessier-Lavigne M. Axon guidance by diffusible chemoattractants: a gradient of netrin protein in the developing spinal cord. J Neurosci 2006, 26(34):8866-8874.
4. Haugh J.M., Codazzi F., Teruel M., Meyer T. Spatial sensing in fibroblasts mediated by 3' phosphoinositides. J Cell Biol 2000, 151(6):1269-1280.
5. Schneider I.C., Haugh J.M. Quantitative elucidation of a distinct spatial gradient-sensing mechanism in fibroblasts. J Cell Biol 2005, 171(5):883-892.
6. Makanya A.N., Stauffer D., Ribatti D., Burri P.H., Djonov V. Microvascular growth, development, and remodeling in the embryonic avian kidney: the interplay between sprouting and intussusceptive angiogenic mechanisms. Microsc Res Tech 2005, 66(6):275-288.
7. Raftery L.A., Sutherland D.J. Gradients and thresholds: BMP response gradients unveiled in Drosophila embryos. Trends Genet 2003, 19(12):701-708.
8. Veitia R.A., Salazar-Ciudad I. Commonalities in fly embryogenesis and mammalian pituitary patterning. Trends Endocrinol Metab 2007, 18(7):261-265.
9. Hao X., Silva E.A., Mansson-Broberg A., Grinnemo K.H., Siddiqui A.J., Dellgren G., et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res 2007, 75(1):178-185.
10. Ennett A.B., Kaigler D., Mooney D.J. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A 2006, 79(1):176-184.
11. Phillippi J.A., Miller E., Weiss L., Huard J., Waggoner A., Campbell P. Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle- and bone-like subpopulations. Stem Cells 2008, 26(1):127-134.
12. McDevitt T.C., Angello J.C., Whitney M.L., Reinecke H., Hauschka S.D., Murry C.E., et al. In vitro generation of differentiated cardiac myofibers on micropatterned laminin surfaces. J Biomed Mater Res 2002, 60(3):472-479.
13. McDevitt T.C., Woodhouse K.A., Hauschka S.D., Murry C.E., Stayton P.S. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J Biomed Mater Res A 2003, 66(3):586-595.
14. Kim D.N., Lee W., Koh W.G. Micropatterning of proteins on the surface of three-dimensional poly(ethylene glycol) hydrogel microstructures. Anal Chim Acta 2008, 609(1):59-65.
15. Campbell P.G., Miller E.D., Fisher G.W., Walker L.M., Weiss L.E. Engineered spatial patterns of FGF-2 immobilized on fibrin direct cell organization. Biomaterials 2005, 26(33):6762-6770.
16. Campbell P.G., Weiss L.E. Tissue engineering with the aid of inkjet printers. Expert Opin Biol Ther 2007, 7(8):1123-1127.
17. Hong S., Lee D., Zhang H., Zhang J.Q., Resvick J.N., Khademhosseini A., et al. Covalent immobilization of p-selectin enhances cell rolling. Langmuir 2007, 23(24):12261-12268.
18. Miller E.D., Fisher G.W., Weiss L.E., Walker L.M., Campbell P.G. Dose-dependent cell growth in response to concentration modulated patterns of FGF-2 printed on fibrin. Biomaterials 2006, 27(10):2213-2221.
19. Wright D., Rajalingam B., Karp J.M., Selvarasah S., Ling Y., Yeh J., et al. Reusable, reversibly sealable parylene membranes for cell and protein patterning. J Biomed Mater Res A 2007, 85(2):530-538.
20. Storrie H., Mooney D.J. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev 2006, 58(4):500-514.
21. Jang J.H., Houchin T.L., Shea L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004, 1(1):127-138.
22. Godbey W.T., Wu K.K., Mikos A.G. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999, 60(2-3):149-160.
23. Christman K.L., Fang Q., Yee M.S., Johnson K.R., Sievers R.E., Lee R.J. Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 2005, 26(10):1139-1144.
24. Huang Y.-H., Zugates G.T., Peng W., Holtz D., Dunton C., Green J.J., et al. Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res 2009, 69(15):6184-6191.
25. De Laporte L., Huang A., Ducommun M.M., Zelivyanska M.L., Aviles M.O., Adler A.F., et al. Patterned transgene expression in multiple-channel bridges after spinal cord injury. Acta Biomater 2010, 6(8):1889-1897.
26. Houchin-Ray T., Swift L.A., Jang J.-H., Shea L.D. Patterned PLG substrates for localized DNA delivery and directed neurite extension. Biomaterials 2007, 28(16):2603-2611.
27. Laporte L.D., Yang Y., Zelivyanskaya M.L., Cummings B.J., Anderson A.J., Shea L.D. Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther 2008, 17(2):318-326.
28. Clackson T. Regulated gene expression systems. Gene Ther 2000, 7(2):120-125.
29. Alexander H.K., Booy E.P., Xiao W., Ezzati P., Baust H., Los M. Selected technologies to control genes and their products for experimental and clinical purposes. Arch Immunol Ther Exp (Warsz) 2007, 55(3):139-149.
30. Vilaboa N., Voellmy R. Regulatable gene expression systems for gene therapy. Curr Gene Ther 2006, 6(4):421-438.
31. Goverdhana S., Puntel M., Xiong W., Zirger J.M., Barcia C., Curtin J.F., et al. Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther 2005, 12(2):189-211.
32. Karzenowski D., Potter D.W., Padidam M. Inducible control of transgene expression with ecdysone receptor: gene switches with high sensitivity, robust expression, and reduced size. Biotechniques 2005, 39(2):191-192. 4, 6 passim.
33. Kumar M.B., Potter D.W., Hormann R.E., Edwards A., Tice C.M., Smith H.C., et al. Highly flexible ligand binding pocket of ecdysone receptor. J Biol Chem 2004, 279(26):27211-27218.
34. Palli S.R., Kapitskaya M.Z., Kumar M.B., Cress D.E. Improved ecdysone receptor-based inducible gene regulation system. Eur J Biochem 2003, 270(6):1308-1315.
35. Guan J., Sacks M.S., Beckman E.J., Wagner W.R. Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. J Biomed Mater Res 2002, 61(3):493-503.
36. Cho Y.W., Lee J., Lee S.C., Huh K.M., Park K. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release 2004, 97(2):249-257.
37. Lao L.L., Venkatraman S.S., Peppas N.A. A novel model and experimental analysis of hydrophilic and hydrophobic agent release from biodegradable polymers. J Biomed Mater Res A 2009, 90(4):1054-1065.
38. Solomon O.F., Ciuta I.Z. Determination of the intrinsic viscosity of polymer solutions by a simple determination of viscosity. J Appl Polym Sci 1962, 6(24):683-686.
39. Li Y., Ma T., Kniss D.A., Lasky L.C., Yang S.T. Effects of filtration seeding on cell density, spatial distribution, and proliferation in nonwoven fibrous matrices. Biotechnol Prog 2001, 17(5):935-944.
40. Stankus J.J., Guan J., Fujimoto K., Wagner W.R. Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 2006, 27(5):735-744.
41. Lessard J., Aicha S.B., Fournier A., Calvo E., Lavergne E., Pelletier M., et al. Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format. Prostate 2007, 67(8):808-819.
42. Fujimoto K.L., Guan J., Oshima H., Sakai T., Wagner W.R. In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures. Ann Thorac Surg 2007, 83(2):648-654.
43. Fujimoto K.L., Tobita K., Merryman W.D., Guan J., Momoi N., Stolz D.B., et al. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol 2007, 49(23):2292-2300.
44. Hashizume R., Fujimoto K.L., Hong Y., Amoroso N.J., Tobita K., Miki T., et al. Morphological and mechanical characteristics of the reconstructed rat abdominal wall following use of a wet electrospun biodegradable polyurethane elastomer scaffold. Biomaterials 2010, 31(12):3253-3265.
45. Nieponice A., Soletti L., Guan J., Hong Y., Gharaibeh B., Maul T.M., et al. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A 2010, 16(4):1215-1223.
46. Grad S., Kupcsik L., Gorna K., Gogolewski S., Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials 2003, 24(28):5163-5171.
47. Rashid S.T., Fuller B., Hamilton G., Seifalian A.M. Tissue engineering of a hybrid bypass graft for coronary and lower limb bypass surgery. FASEB J 2008, 22(6):2084-2089.
48. Sharifpoor S., Labow R.S., Santerre J.P. Synthesis and characterization of degradable polar hydrophobic ionic polyurethane scaffolds for vascular tissue engineering applications. Biomacromolecules 2009, 10(10):2729-2739.
49. Guan J., Stankus J.J., Wagner W.R. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release 2007, 120(1-2):70-78.
50. Amsden B.G. Biodegradable elastomers in drug delivery. Expert Opin Drug Deliv 2008, 5(2):175-187.
51. Liu J., Xiao Y., Allen C. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci 2004, 93(1):132-143.
52. Ieda M., Fu J.-D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142(3):375-386.
53. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
54. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009, 459(7247):708-711.
55. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110(3):385-397.
56. Zhou Q., Brown J., Kanarek A., Rajagopal J., Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to [bgr]-cells. Nature 2008, 455(7213):627-632.
57. Wescoe K.E., Schugar R.C., Chu C.R., Deasy B.M. The role of the biochemical and biophysical environment in chondrogenic stem cell differentiation assays and cartilage tissue engineering. Cell Biochem Biophys 2008, 52(2):85-102.
58. DeLise A.M., Tuan R.S. Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J Cell Biochem 2002, 87(3):342-359.
59. Cress D.E. The need for regulatable vectors for gene therapy for Parkinson's disease. Exp Neurol 2008, 209(1):30-33.